Could viruses be used to treat acne?
Scientists have isolated and studied the genomes of 11 viruses, known as phage, that can infect and kill the acne-causing bacterium Propionibacterium acnes, potentially paving the way for topical therapies that use viruses or viral products to treat this vexing skin condition. Their results are reported in mBio®.
"There are two fairly obvious potential directions that could exploit this kind of research," says Graham Hatfull of the University of Pittsburgh, an author of the study. "The first is the possibility of using the phages directly as a therapy for acne. The second is the opportunity to use phage-derived components for their activities."
P. acnes is a normal resident on human skin, but its numbers increase substantially at puberty, eliciting an inflammatory response that can lead to acne. Although antibiotics can be effective in treating acne, antibiotic-resistant strains of P. acnes have emerged, highlighting the need for better therapies.
Hatfull and his colleagues at the University of Pittsburgh along with scientists from the University of California, Los Angeles, isolated phages and P. acnes bacteria from human volunteers with and without acne, then sequenced the phages' genomes. What they found in those genomes was surprising. The phages were all remarkably similar, sharing more than 85% of their DNA, an unheard of level of similarity among viruses, which usually exhibit a great deal of diversity. This lack of genetic diversity suggests that resistance to phage-based antimicrobial therapy is less likely to develop, they say.
All of the phages carry a gene that makes a protein called endolysin, an enzyme that is thought to break down bacterial cell walls and kill the bacteria. Enzymes like this are used in other applications, says Hatfull, suggesting that endolysin from these phages might also be useful as a topical anti-acne therapeutic. "This work has given us very useful information about the diversity of that set of enzymes and helps pave the way for thinking about potential applications," he says.
From here, Hatfull says, research with these phages will explore how they might be used therapeutically, but phages like these can also provide useful tools, like genes and enzymes, that can be used to manipulate and understand the bacteria they infect. "The information derived from these phages helps contribute toward those kinds of genetic tools," says Hatfull.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Caffeine appears to be beneficial in males - but not females - with Lou Gehrig's disease
Researchers study the human factor in spread of pandemic illness

How CRISPR can help fight against neurodegenerative diseases - Scientists listed ways of applying genetic engineering to treat Parkinson's disease

Stem Cells May Speed Up Screening of Drugs for Rare Cancers

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus
Removab Approval: Proof-of-Concept for Technology Transfer in Germany

Decoding Blood Platelet Production: The Intricate Role of Lipids - Disruptions in lipid metabolism might affect platelet production

Excessive fluid consumption: habit or hormonal disorder? - Which test provides a reliable diagnosis?

Molecular switch may serve as new target point for cancer and diabetes therapies
HIV/AIDS long-term costs high - and unaffordable to most-affected countries
Part of hagfish slime mystery solved
